APA (7th ed.) Citation

HM, E., RA, Y., TM, M., A, A., & NK, A. (2026). Low-dose DOX-polygodial nanosystem modulates the CD47/CALR axis for safer triple negative breast cancer treatment. Nanoscale advances, 8(7), 2333. https://doi.org/10.1039/d5na01082a

Chicago Style (17th ed.) Citation

HM, Emara, Youness RA, Manie TM, Abdelnaser A, and Allam NK. "Low-dose DOX-polygodial Nanosystem Modulates the CD47/CALR Axis for Safer Triple Negative Breast Cancer Treatment." Nanoscale Advances 8, no. 7 (2026): 2333. https://doi.org/10.1039/d5na01082a.

MLA (9th ed.) Citation

HM, Emara, et al. "Low-dose DOX-polygodial Nanosystem Modulates the CD47/CALR Axis for Safer Triple Negative Breast Cancer Treatment." Nanoscale Advances, vol. 8, no. 7, 2026, p. 2333, https://doi.org/10.1039/d5na01082a.